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Abstract
OBJECTIVE: To study the functional mechanism of
Pingchuanning Decoction in treatment of airway
remodeling in asthmatic rats.
METHODS: Eighty healthy Wistar male rats were
randomized into eight groups (n=10 rats each): Nor-
mal group, Asthma model group, Dexamethasone
group, Guilong Kechuanning group, Xiaoqinglong
Decoction group, and Pingchuanning Decoction
low-, middle-, and high-dose groups. The rats of all
but the Normal group were made into asthma mod-
els through intraperitoneal injection and aerosol in-
halation of ovalbumin. All treatments were adminis-
tered at the first stimulation of asthma onset (third
week of modeling), and the rats were killed after
stimulating asthma attacks for 4 weeks. The general
conditions of rats and pathomorphological chang-
es of the lung tissues were observed.The expres-
sion of nerve growth factor (NGF) of the lung tis-
sues was measured with immunohistochemical
methods, and the content of Clara cell secretory
protein (CCSP) mRNA was determined with RT-PCR.
RESULTS: Compared with the Normal group, the
contents of NGF and CCSP mRNA in the lung tis-
sues of the Model group were significantly
changed (P<0.01). Compared with the Model
group, the indices of Pingchuanning Decoction
and other treatment groups were improved to
some extent (P<0.05 or P<0.01).
CONCLUSIONS: Pathological changes of airway in-
flammation and remodeling were present in these
rat asthma models. Pingchuanning Decoction had
an intervention effect on these experimental mod-
els. Its functional mechanism may be related to
multiple factors, including alleviation of airway in-
flammation, relief of bronchial smooth muscle
spasm, and inhibition of airway remodeling.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Bronchial asthma (hereafter referred to as asthma) is a
chronic airway inflammatory disease involving many
kinds of cells and cellular components. Its basic patho-
logical changes are airway inflammation, airway hyper-
responsiveness, and airway remodeling. The concept of
airway remodeling was first proposed by Huber and
Koessler in 1922. The morphological manifestations of
asthma are thickening of the airway walls, increasing of
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the cross-sectional area of airway walls, and narrowing
of the inner diameter of airways. Nerve growth factor
(NGF) plays an important role in the inflammatory re-
sponse under conditions of airway inflammation, and
it participates the airway remodeling through its au-
to-secretion.Clara cells and Clara cell secretory protein
(CCSP) may offer protection in the process of airway
inflammatory injury,repair,and remodeling in asthma[1].
This study was performed to evaluate the effect of Ping-
chuanning Decoction on asthma by observing NGF
and CCSP levels in lung tissues of rats with asthma
based on previous studies.
METHODS
Experimental animals
Eighty healthy male Wistar rats weighing 200 ± 20 g
were selected for this experiment. The rats and forage
were provided by the Experimental Animal Center of
Anhui Medical University.
Medicines and reagents
Materials and equipment for this study were as follows:
ovalbumin (OVA) (production batch number: A8040;
Sigma, US), dexamethasone (production batch num-
ber: 100402; Shanghai Xinyi Pharmaceutical Co.,
Ltd.), Guilong Kechuanning capsules (production
batch number: 100605; Shanxi Guilong Medicine Co.,
Ltd.), Pingchuanning Decoction (Anhui Weimin Phar-
macy), Xiaoqinglong Decoction (Anhui Weimin Phar-
macy), ultrasonic nebulizer (Jiangsu Yuyue Medical
Equipment Co., Ltd.), and HH-2 digital constant tem-
perature water bath cabinet (Jiangsu Jintan Ronghua
Instrument Manufacturing Co., Ltd.).
The main reagents and instruments for the pathologi-
cal study were an embedding machine (Changzhou
Zhongwei Electron Instrument Co.), RM2126 paraffin
microtome (Leica, Germany), and photomicroscope
(Olympus, Japan).
The main reagents for the immunohistochemical study
were an anti-NGF and DAB reagent box (Beijing Bio-
synthesis Biotechnology Co., Ltd.) and an SP immuno-
histochemistry kit (Beijing Biosynthesis Biotechnology
Co., Ltd.).
The main reagents and instruments for the RT-PCR
study were DEPC (Gibco, US), TRIZOL Reagent (In-
vitrogen, US), RT-PCR kit (Shanghai Biological Engi-
neering Co., Ltd.), primer synthesis (Shanghai Biologi-
cal Engineering Co., Ltd.), PCR marker (100, 250,
500, 750, 1000, and 2000 bP; Takara, Japan), low-tem-
perature high-speed centrifuge (Shanghai Minqiao Pre-
cision Instrument Co., Ltd.), UV-visible spectropho-
tometer (Biometra, Germany), PCR instrument (Ep-
pendorf, Germany), electrophoresis apparatus (Beijing
Liuyi Instrument Factory), and gel density scanners
and Labworks 3.0 analysis software (UVP, US).
Grouping
Eighty male Wistar rats were randomized into eight
groups (n=10 rats each): A, Normal group; B, Asthma
model group; C, Dexamethasone group; D, Guilong
Kechuanning group; E, Xiaoqinglong Decoction
group; F, Pingchuanning Decoction low-dose group;
G, Pingchuanning Decoction middle-dose group; and
H,Pingchuanning Decoction high-dose group.Animals
were kept and fed in a room temperature (22±2)°C en-
vironment for 7 days for adaptive feeding before mod-
eling.
Modeling
After adaptive feeding for 7 days, the asthma modeling
was begun[2]. Groups B, C, D, E, F, G, and H received
1 mL of 10% OVA suspension by intraperitoneal injec-
tion on days 1 and 8 of modeling. Group A received 1
mL of normal saline instead of OVA suspension. Two
weeks later, Groups B, C, D, E, F, G, and H were
placed in sealed glass containers and nebulized with
1% OVA solution for 20 min once a day for 4 weeks.
Successful asthma attack stimulation was manifested as
an increased respiratory rate, lip cyanosis, abdominal
cramps, breathng with nod, and unstable standing.
Group A was nebulized with normal saline.
Preparation of medicines
Composition of Pingchuanning Decoction: Mahuang
(Herba Ephedrae) 9 g, Xi Xin (Radix et Rhizoma Asa-
ri) 3 g, Su Zi (Fructus Perillae) 6 g, Xing Ren (Semen
Armeniacae Amarum) 9 g, Chen Pi (Pericarpium Citri
Reticulatae) 6 g, Ban Xia (Rhizoma Pinelliae) 9 g,
Huang Qi (Radix Astragali) 9 g, Tai Zi Shen (Radix
Pseudostellariae) 9 g, Fang Feng (Radix Saposhnikovi-
ae) 6 g, Di Long (Pheretima) 6 g, and Zhe Bei Mu
(BulBbus Fritillariae Thunbergii) 9 g.
Preparation: The standard dose of crude medicine re-
quired based on each animal's body weight was con-
verted from the standard dose for human body weight
with the formula (Db = Da·Rab)[3], which equated to
9.80 g crude medicine per kilogram of rat body
weight. The Pingchuanning Decoction high dose was
19.60 g/kg (Group F), middle-dose was 9.80 g/kg
(Group G), and low dose was 4.90 g/kg (Group H).
The middle dose was equal to the dose for clinical use
in adults, twice the low dose, and half the high dose.
The medicines were soaked in distilled water for 1 h,
removed and placed into an earthenware casserole, and
decocted three times with a slow fire for 30 min after
boiling. The decoctions were mixed and concentrated
to 0.98 g crude medicine/mL. A portion of this mix-
ture was then concentrated to 1.96 g crude medicine/
mL, and another portion was diluted to 0.49 g crude
medicine/mL. The final product was stored in the re-
frigerator until ready for use.
Dexamethasone: The tablets were crushed and dis-
solved with normal saline to a concentration of 0.04
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mg/mL. The final product was stored in the refrigera-
tor until ready for use.
Guilong Kechuanning capsules: The powder was
poured out and dissolved with normal saline to a
concentration of 1 g/mL. The final product was
stored in the refrigerator until ready for use.
Composition of Xiaoqinglong Decoction: Ma
Huang (Herba Ephedrae), Xi Xin (Radix et Rhi-
zoma Asari), Shao Yao (Radix Paeoniae), Fa Ban Xia
(Rhizoma Pinelliae Praeparatum), Gui Zhi (Ramulus
Cinnamomi), Wu Wei Zi (Fructus Schisandrae Chi-
nensis), Gan Jiang (Rhizoma Zingiberis), and Zhi
Gan Cao (Radix et Rhizoma Glycyrrhizae Praeparata
cum Melle).
Preparation: According to the original party propor-
tion and decocting requirements of the original pre-
scription, the medicines were decocted and the de-
coction was paired with distilled water to a concen-
tration of 1 g crude medicine/mL.
The rats were administered treatments daily 30 min
before stimulating asthma onset. Groups A and B
were given equal amounts of distilled water per ad-
ministration every day. Group C was administered
dexamethasone 0.4 mg/kg daily. Group D was ad-
ministered Guilong Kechuanning 10 g/kg daily.
Group E was administered Xiaoqinglong Decoction
10 g/kg daily. Group F was administered Pingchuan-
ning Decoction 4.9 g/kg daily. Group G was admin-
istered Pingchuanning Decoction 9.8 g/kg daily.
Group H was administered Pingchuanning Decoc-
tion 19.6 g/kg daily. The doses for Groups F, G,
and H were 0.5, 1, and 2 times the adult daily
dose. The intragastric volume was identical to that
at 25 mL/kg body weight. After the experiment was
finished, the administrations were stopped and fast-
ing was adopted for 1 day before obtaining the ex-
perimental materials.
Detection of NGF in lung tissues
The dewaxed paraffin sections were stained with im-
munohistochemical reagent box (SABC method).
The concentration of anti-NGF was 1%. The nega-
tive control was phosphate-buffered saline. The pro-
cedure was performed following the instructions of
the immunohistochemical detection kit. The gray
value of the NGF expression area was measured by
the MIAS-2000 Medical Image Analysis System.
NGF was expressed as brown granular material and
was present mainly in the cytoplasm of airway epi-
thelial cells, smooth muscle cells, and lung intersti-
tial cells. Five horizons were taken from every im-
munohistochemical staining section under high mag-
nification. The positive-area gray values of each hori-
zon were detected, and the average gray values (A)
were calculated by the same observer.
Detection of total RNA in lung tissues
After euthanasia, the left lower lung was removed
and stored in liquid nitrogen. The total RNA in 100
mg of lung tissues was extracted with a one-step
method. The RNA content was measured by a UV
spectrophotometer. All materials were soaked in
DEPC water overnight, sterilized by high pressure,
and dried. All operations were carried out on ice.
RT-PCR
Reagents and total RNA were added one by one ac-
cording to the kit instructions. The reaction volume
was 25 μL. The primer design of expressed genes ac-
cording to RT-PCR were as follows.
Gene name
GAPDH
CCSP
Primers
forward: 5′-ACCACAGTCCATGCCATCAC-3′
reverse: 5′-TCCACCACCCTGTTGCTGTA-3′
forward: 5′-CATCAGCCCACATCTACAGAC-3′
reverse: 5′-GGGCTTTAGCGTAGAATATCT-3′
PCR product length
452 bp
373 bp
Operation
1) Template RNA (1 μL), oligo (dT) 18 (1 μL), and
nuclease-free water (10 μL) were added to 0.2-mL EP
tubes. They underwent centrifugal mixing for a few sec-
onds, hatching at 70°C for 5 min, and rapid quench-
ing on ice for 10 min. 2) Next, 5 × buffer (4 μL),
dNTP mixture (2 μL), RNase inhibitor (40 U/μL) (1μL), reverse transcriptase (1 μL), and nuclease-free wa-
ter were added to a total volume of 25 μL. 3) Centrifu-
gal mixing was performed at 42°C for 60 min and 72°
C for 10 min. Then, cDNA was obtained for PCR am-
plification. 4) Nuclease-free water (8.5 μL), cDNA (2μL), forward primer (10 μmol/l) (1 μL), reverse prim-
er (10 μmol/L) (1 μL), and PCR Master Mix (12.5μL) were added. Reaction conditions were as follows:
GAPDH 94°C, 5 min; 94°C, 45 s; 60°C, 60 s; 72°C,
60 s, 35 cycles; 72°C, 7 min; CCSP 94°C, 5 min; 94°
C, 45 s; 60°C, 60 s; 72°C, 60 s, 35 cycles; 72°C, 10
min. 5) PCR products were stored at 4°C until ready
for electrophoresis.
Detection of CCSP mRNA expression with Sq RT-
PCR
The PCR products of CCSP and GAPDH were respec-
tively added (5 μL each) along with the loading buffer
(1 μL) into 1% agarose gel and electrophoresed for 40
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min at 100 V. The average optical density of each band
was analyzed with the GDS gel imaging system. The
relative expression of CCSP was calculated with GAP-
DH as an internal reference.
Determination of RT-PCR products
After purification, the RT-PCR products were mea-
sured by an ABI PRISM 377 automatic sequencer and
compared with the CCSP sequence published in the lit-
erature.
Statistical analyses
SPSS17.0 software was used for statistical analyses. Da-
ta were presented as mean ± standard error ( xˉ ± s).
ANOVA for among-group comparison, SNK test for
two-two comparison between groups, and correlation
analysis for analysis of the correlation between factors
were adopted. A P-value of <0.05 was considered statis-
tically significant.
RESULTS
Immunohistochemical changes of NGF in lung tissues
Table 1 Comparison of immunohistochemical result of NGF
in lung tissues ( xˉ ±s)
Group
A
B
C
D
E
F
G
H
Rats(n)
10
8
9
9
8
8
9
9
Dose g·
kg-1·d-1)
－
－
0.4
10
7.8
4.9
9.8
19.6
Average gray value (A)
81.326 ± 3.136
115.389 ± 2.839**
95.648 ± 3.032*▲▲
96.562 ± 2.974*▲
96.895 ± 2.373*▲
99.276 ± 3.317*▲
96.020 ± 2.648*▲▲
96.630 ± 2.825*▲▲
Note: Compared with the normal group: *P<0.05, **P<0.01;
compared with the model group: ▲P<0.05, ▲▲P<0.01.
The data of NGF expression in the lung tissues of each
group were analyzed by analysis of variance (F=123.1,
P<0.01) and further by the SNK test: 1) Compared
with the Normal group, the NGF expression in the
lung tissues of the Model group was significantly differ-
ent (P<0.01). 2) Compared with the Model group, the
NGF expressions in the lung tissues of all treatment
groups were different (P<0.05, P<0.01). 3) In compari-
son of the Pingchuanning Decoction middle- and
high-dose groups with the Dexamethasone group,
there was no significant difference (P>0.05). In com-
parison of the Guilong Kechuanning group with the
Xiaoqinglong Decoction group, there was no signifi-
cant difference (P>0.05). In comparison of the Dexa-
methasone group with the Guilong Kechuanning
group, there was a significant difference (P<0.05). In
comparison among the Pingchuanning Decoction
groups, the high- and middle-dose groups were better
than the low-dose group (P<0.05) (Figures 1-8). There
was a significant positive correlation between NGF ex-
pression in the lung tissues and bronchial wall thick-
ness as shown in the correlation analysis (r=0.924492,
P<0.05).
Changes in CCSP mRNA in lung tissues
Table 2 Comparison of the relative contents of CCSP mRNA
in lung tissues of rats ( xˉ ±s)
Group
A
B
C
D
E
F
G
H
Rats(n)
10
8
9
9
8
8
9
9
Dose(·kg-1·d-1)
－
－
0.4
10
7.8
4.9
9.8
19.6
CCSP mRNA
0.67 ± 0.045
0.49 ± 0.038**
0.61 ± 0.072*▲▲
0.57 ± 0.023*▲▲
0.56 ± 0.019*▲
0.55 ± 0.094*▲
0.60 ± 0.091*▲▲
0.59 ± 0.057*▲▲
Note: Compared with the normal group: *P< 0.05, **P< 0.01;
compared with the model group: ▲P< 0.05, ▲▲P< 0.01.
The data of CCSP mRNA expression in the lung tis-
sues of each group were analyzed by analysis of vari-
ance F=7.497, P<0.01) and further by the SNK test: 1)
Compared with the Normal group, the CCSP mRNA
expression in the lung tissues of the Model group was
significantly different (P<0.01). 2) Compared with the
Model group, the CCSP mRNA expressions in the
lung tissues of all treatment groups were different (P<
0.05, P<0.01). 3) In comparison of the Pingchuanning
Decoction middle- and high-dose groups with the
Dexamethasone group, there was no significant differ-
ence (P>0.05). In comparison of the Guilong Kechuan-
ning group with the Xiaoqinglong Decoction group,
there was no significant difference (P>0.05). In com-
parison of the Dexamethasone group with the Guilong
Kechuanning group, there was a significant difference
(P<0.05). In comparison, among the Pingchuanning
Decoction groups, the high- and middle-dose groups
were better than the low-dose group (P<0.05) (Figures
9, 10). There was a significant negative correlation be-
tween the CCSP mRNA expression in the lung tissues
and bronchial wall thickness as shown in the correla-
tion analysis (r=0.986541, P<0.05).
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Immunohistochemical Staining of NGF
Figure 1 Normal group (×400). Figure 2 Model group (×400).
Figure 3 Dexamethasone group (×400). Figure 4 Guilong Kechuanning group (×400).
Figure 5 Xiaoqinglong Decoction group (×400). Figure 6 Pingchuanning low-dose group (×400).
Figure 7 Pingchuanning middle-dose group (×400). Figure 8 Pingchuanning high-dose group (×400).
Electrophoresis of the PCR Product of CCSP mRNA
Figure 9 GAPDH electrophoresis. Figure 10 CCSP mRNA electrophoresis.
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DISCUSSION
Bronchial asthma is a chronic airway inflammatory dis-
ease involving a variety of cells and cellular compo-
nents. It is a polygenic hereditary disease affected by en-
vironmental factors. The main pathological changes are
immune inflammatory infiltration, airway hyperrespon-
siveness, and airway remodeling. It belongs to the
Xiao-asthma syndrome in TCM. According to TCM,
the main pathogenesis of this disease is invasion of the
body surface by the exogenous pathogen, and
phlegm-fluid affects the lung, which fails to disperse
and descend. The phlegm-fluid causes Qi stagnation,
leading to an obstruction of qi of the lung. The repeat-
ed asthma attacks, followed by spleen and kidney defi-
ciency and liver Qi stagnation, result in the failure of
the lung to disperse and descend. In emergency cases,
the acute symptoms are treated first; when these are re-
lieved, the fundamental cause is treated. For acute at-
tacks of asthma cold syndrome, the main treatment
principle is to dispel wind cold and dissolve phlegm to
relieve the asthmatic breathing with regulation of Qi
and activation of blood. Reinforcement of Qi and
strengthening of the spleen is the accessory treatment.
Pingchuanning Decoction is modified from Shegan
Mahuang Tang (Belamcanda and Ephedra Decoction)
and Sanzi Yangqin Tang (Three-Seed Filial Devotion
Decoction). It is an effective prescription for asthma
cold syndrome. It comprises 11 medicines that func-
tion well in warming the lung, dissolving phlegm, stop-
ping cough and asthma, expelling wind, relieving
spasm, regulating Qi, and activating blood.
NGF is a member of the neurotrophic factor family. It
is expressed in a variety of cells of different structures
and inflammatory cells in the lung tissues, playing an
important role in airway inflammation, hyperrespon-
siveness, and remodeling[4]. After allergen inhalation,
an immediate or delayed allergic reaction occurs, induc-
ing acute attack of asthma and accumulation and acti-
vation of inflammatory cells in the airway. These cells
further release inflammatory mediators, postponing
the anti-inflammatory response. Therefore, airway re-
modeling is the result. NGF can stimulate sensory neu-
rons to secrete calcitonin gene-related peptide or tachy-
kinin, causing neurogenic inflammation by changing
airway neurons and their afferent nerve fibrous func-
tions and aggravating the airway inflammation that al-
ready exists[5]. After antigen stimulation, NGF inte-
grates with the surface receptors of mast cells, pro-
motes mast cell release into inflammatory reaction me-
dium, adds immediate hypersensitivity, and causes per-
sistent high reactivity of the airway through the remod-
eling network of airway neurons[6]. NGF induces
smooth muscle remodeling and subepithelial fibrosis,
excessive blood vessel formation, excessive nerve regen-
eration, and smooth muscle hyperplasia[7], possibly
through autocrine regulation of these cells in airway re-
modeling. NGF can increase the release of vascular en-
dothelial growth factor to promote angiogenesis in air-
way smooth muscle proliferation and airway remodel-
ing in asthma[8,9]. Matrix metalloproteinase-2 (MMP-2)
can promote the proliferation of myofibroblasts. Induc-
tion of MMP-2 expression by NGF may be one of the
mechanisms of inflammation and airway remodeling
in asthma[10].
In the present study, the NGF expression in the lung
of the Model group was significantly higher than that
of the Normal group, and was positively correlated
with the degree of airway remodeling (bronchial wall
thickness). It can thus be predicted that NGF may be-
come the key link in evaluation of airway remodeling
severity, diagnosis, and treatment in asthma in the fu-
ture. Among the treatment groups, the NGF expres-
sion in the Pingchuanning Decoction groups was sig-
nificantly lower than that in the Model group, but still
higher than that in the Normal group. This indicates
that Pingchuanning Decoction can inhibit NGF ex-
pression and reduce airway inflammation and smooth
muscle remodeling. The effect of a middle dose is as ef-
fective as that of dexamethasone.
A decrease of the level of CCSP has been found in
bronchoalveolar lavage fluid (BALF)[11] and serum[12] of
asthma patients. Immunohistochemical studies showed
decreased numbers of Clara cells in the small airways.
This decrease in Clara cells and CCSP in asthma pa-
tients would result in more epithelial injury and genera-
tion of inflammatory mediators in the airways, causing
or aggravating the airway inflammation. Thus, pulmo-
nary CCSP reduction or absence has close ties with
bronchial asthma[13].
After antigen inhalation, phospholipase A2 and arachi-
donic acid contents are significantly increased in the
airways patients with asthma. CCSP is a strong inhibi-
tor of phospholipase A2 in reducing the release of in-
flammatory mediators such as prostaglandin, throm-
boxane A2, leukotrienes, and platelet activators, which
are derived from arachidonic acid. In addition, CCSP
can inhibit the production of interferon-γ, interleu-
kin-1, interleukin-6, and tumor necrosis factor-α and
the biological activity of IFN-γ, and decrease the che-
motactic activity of macrophages and neutrophils.
In a pathological study involving Clara cell secretory
protein gene-deficient rats (CCSP-/-) and wild rats
(CCSP+/+) sensitized by OVA, Wang et al.[14] observed
that the number of neutrophils in BALF of CCSP+/+
rats increased significantly, myeloperoxidase activity
and macrophage inflammatory protein-α levels in-
creased, and lung inflammation was enhanced. This
suggests that CCSP plays an important role in the inhi-
bition of allergic inflammation in asthma.
Airway remodeling is a pathological change involving
airway wall thickening, subepithelial fibrosis, smooth
muscle hypertrophy, myofibroblast proliferation, sali-
vary gland metaplasia, increased extracellular matrix de-
220
JTCM |www. journaltcm. com June 15, 2012 |volume 32 | Issue 2 |
Fang XM et al. Mechanism of Pingchuanningon adjustment of CCSP in airway remodeling of asthmatic rats
position, etc. It is a complex, progressive process. Feh-
renbach et al.[15] found that keratinocyte growth factor
could promote the proliferation of bronchial epithelial
cells, which are CCSP-positive cells only; consequently,
Clara cells were found to be important in repairing
bronchial epithelial injury.
Lesur et al.[16] found that CCSP was significantly lower
in the BALF and plasma of patients with asthma, the
CCSP level in plasma depended on the genotype of
CCSP, the changes in the CCSP gene on the 38th bit
might be related to asthma, the plasma CCSP level
could reflect the decreased secretion of CCSP caused
by small airway remodeling, and the level of CCSP was
unrelated to the steady state or onset of asthma but was
related to the course of asthma.
Luo et al.[17] found that Clara cells decreased in number
and bronchial walls thickened in asthmatic rats. They
conjectured that Clara cells secreted less CCSP in the
process of repairing epithelial injury in airway inflam-
mation. The reduction in Clara cells led to delayed re-
pair of epithelial injury, and fibroblast migration to the
subepithelial level played the role of alternative repair,
thus promoting remodeling.
In the present study, the CCSP mRNA content, name-
ly the CCSP expression, in the lung tissues of the Mod-
el group was significantly lower than that in the Nor-
mal group and was negatively correlated with the sever-
ity of airway remodeling (bronchial wall thickness).
This is why CCSP may become an evaluation factor in
determination of airway remodeling severity and treat-
ment of airway remodeling in the future. Among the
treatment groups, the CCSP expression in the Pingch-
uanning Decoction groups was significantly higher
than that in the Model group but still lower than that
in the Normal group. This indicates that Pingchuan-
ning Decoction can promote CCSP expression, reduce
airway inflammation, and delay the repair of epithelial
injury and that a middle dose is as effective as dexa-
methasone.
The results of this study show that Pingchuanning De-
coction is effective in lowering the NGF level and in-
creasing CCSP expression. In this way, it intervenes in
airway remodeling in patients with asthma. Detailed
studies on the pathogenesis of airway remodeling con-
tribute to the control of asthma. Today, when preven-
tion and control of asthma is becoming increasingly ur-
gent, the use of TCM is one of the most effective treat-
ment methods.
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